Metacognitive deficits in major depressive disorder

Area of Science:

• Cognitive Neuroscience
• Psychiatry
• Clinical Psychology

Background:

• Major Depressive Disorder (MDD) is a prevalent mental health condition characterized by persistent sadness and loss of interest.
• Metacognition, or the awareness and understanding of one's own thought processes, plays a crucial role in cognitive function and emotional regulation.
• Impaired metacognition has been implicated in various psychiatric disorders, but its specific role in MDD requires further elucidation.

Purpose of the Study:

• To investigate metacognitive performance in patients diagnosed with Major Depressive Disorder (MDD).
• To examine the correlation between metacognitive deficits and the severity of depressive symptoms in MDD patients.
• To explore the potential diagnostic significance of metacognitive impairments in the early stages of MDD for guiding clinical treatment.

Main Methods:

• A cross-sectional study design was employed, comparing 66 MDD patients with 99 healthy controls.
• Participants completed a mental rotation task, with metacognitive performance assessed using a post-decisional confidence rating paradigm.
• Key metrics evaluated included first-order task performance (d'), metacognitive bias (average confidence), metacognitive sensitivity (meta-d'), and metacognitive efficiency (M Ratio).

Main Results:

• MDD patients demonstrated significantly lower performance on the first-order task (d') compared to healthy controls (p < 0.001).
• Metacognitive bias, sensitivity, and efficiency were significantly impaired in the MDD group (p < 0.001 for bias and sensitivity, p = 0.039 for efficiency).
• Depressive symptom severity (HAMD-17 scores) negatively correlated with all measured metacognitive abilities (p < 0.001 for d', confidence, and meta-d'; p = 0.003 for M Ratio).

Conclusions:

• Metacognitive abilities are significantly impaired in individuals with Major Depressive Disorder.
• The extent of metacognitive impairment is directly related to the severity of clinical depressive symptoms.
• Impaired metacognition in MDD is associated with a negative metacognitive bias, highlighting a potential target for therapeutic interventions.